These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 22884060

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
    Bader P, Hölle W, Klingebiel T, Handgretinger R, Benda N, Schlegel PG, Niethammer D, Beck J.
    Bone Marrow Transplant; 1997 Apr; 19(7):697-702. PubMed ID: 9156247
    [Abstract] [Full Text] [Related]

  • 28. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.
    Bacher U, Badbaran A, Fehse B, Zabelina T, Zander AR, Kröger N.
    Exp Hematol; 2009 Jan; 37(1):135-42. PubMed ID: 19100523
    [Abstract] [Full Text] [Related]

  • 29. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
    Ai HS, Yu CL, Wang DH, Guo M, Qiao JH, Shi BF, Sun WJ, Zhang S, Sun QY, Yao B.
    Zhonghua Yi Xue Za Zhi; 2003 Feb 10; 83(3):208-11. PubMed ID: 12812663
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J, Serrano J, Jiménez A, Castillejo JA, Reina ML, González MG, Rodríguez MC, García I, Sánchez J, Maldonado J, Torres A.
    Haematologica; 2000 Feb 10; 85(2):173-80. PubMed ID: 10681725
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation with amelogenin marker.
    Ghaffari SH, Chahardouli B, Gavamzadeh A, Alimoghaddam K.
    Arch Iran Med; 2008 Jan 10; 11(1):35-41. PubMed ID: 18154421
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation.
    Lee KH, Lee JH, Choi SJ, Lee JH, Kim S, Seol M, Lee YS, Kim WK, Kwon MR, Choi SJ, Park CJ, Chi HS, Lee JS.
    Bone Marrow Transplant; 2003 Aug 10; 32(4):423-31. PubMed ID: 12900780
    [Abstract] [Full Text] [Related]

  • 38. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J, Urbano-Ispizua A, Lawler M, Rozman C, Gardiner N, Marín P, Salgado C, Féliz P, McCann S, Montserrat E.
    Exp Hematol; 1998 May 10; 26(5):415-20. PubMed ID: 9590658
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia.
    Candoni A, Toffoletti E, Gallina R, Simeone E, Chiozzotto M, Volpetti S, Fanin R.
    Clin Transplant; 2011 May 10; 25(2):308-16. PubMed ID: 20412098
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.